<?xml version="1.0" encoding="UTF-8"?>
<ref id="B21-pharmaceutics-13-00573">
 <label>21.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Delcaru</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Alexandru</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Podgoreanu</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Grosu</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Stavropoulos</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Carmen Chifiriuc</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Lazar</surname>
    <given-names>V.</given-names>
   </name>
  </person-group>
  <article-title>Microbial biofilms in urinary tract infections and prostatitis: Etiology, pathogenicity, and combating strategies</article-title>
  <source>Pathogens</source>
  <year>2016</year>
  <volume>5</volume>
  <elocation-id>65</elocation-id>
  <pub-id pub-id-type="doi">10.3390/pathogens5040065</pub-id>
 </element-citation>
</ref>
